Navigation Links
Study: Osteoporosis drug reduces bone loss, tumor size in oral cancer
Date:12/13/2010

th oral squamous cell carcinoma cells from cats to create a disease model for the study. They assigned mice to one of four groups: animals with and without tumors that received a placebo treatment, and mice with and without tumors that received a zoledronic acid treatment.

Animals treated with the drug retained twice as much total bone as did mice with cancer that were untreated. The bone that was present after treatment was a combination of reduced loss of pre-existing bone and an increase in new bone formation, said Rosol, also an investigator in Ohio State's Comprehensive Cancer Center.

Powerful images of the animals' skulls revealed that the bone loss was so severe in some untreated animals with cancer that their tooth roots were exposed. In comparison, animals with cancer that received the drug retained enough bone to keep the tooth roots covered with bone. Overall, on average, mice with cancer that received the drug treatment retained enough bone to match the amount of total bone in mice without tumors.

"When there is bone loss, there is formation of new bone to try to compensate for the loss," Rosol said. "The new bone is not perfect, but importantly, drug treatment prevented loss of both pre-existing normal bone and the new bone that formed."

The retention of bone was attributed at least in part to the drug's ability to reduce the number of activated osteoclasts by 52 percent at sites where the tumor and bone met. Osteoclasts are the cells that are responsible for bone resorption.

The cancer cells that were injected into the mice had been altered to contain a protein that creates light so the scientists could track development of the tumors. At day 28, the tumors treated with zoledronic acid were, on average, at least 14 percent smaller than were tumors that were left untreated.

"With less bone resorption, there might be less stimulation of the tumor," Rosol said. "So if you slow down bone loss, it's no
'/>"/>

Contact: Thomas Rosol
rosol.1@osu.edu
614-292-4265
Ohio State University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study: mechanism that controls cell movement linked to tumors becoming more aggressive
2. Illinois study: Ginseng just got better -- not as bitter
3. Study: Ecological effects of biodiversity loss underestimated
4. Study: Fish near coal-fired power plants have lower levels of mercury
5. National study: Abortion does not cause depression or low self-esteem in adolescents
6. VCU study: Team uncovers possible risk gene for schizophrenia
7. Study: 3 out of 4 cats will wear a collar, making it worth a try
8. Study: The bright red of cardinals means less in urban areas
9. Exploratory study: High BMI linked to proximity to convenience stores
10. Study: Darwin was right to worry that marriage to his cousin affected his offspring
11. Study: Carbon monoxide exposure can be reduced during routine anesthesia in kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... the bladders of healthy women differ from bacteria ... according to researchers from Loyola University Chicago Stritch ... July 9, 2014, in the American Society for ... bacterial communities may play a role in female ... a common, yet poorly understood, condition with symptoms ...
(Date:7/9/2014)... associate professor of plant pathology and microbiology ... the 2014 Alexopoulos Prize by the Mycological ... the science of mycology the study of fungi ... plant pathogens, and medically important fungi. , The award ... mycologist. Stajich received the award last month in East ...
(Date:7/9/2014)... As climate change shifts the geographic ranges in which ... it has on their parasites. Does an increased range ... as well? , Not necessarily, says a team of ... Armand Kuris. In a study published in the ... that for some species, the opposite may happen: Hosts ...
Breaking Biology News(10 mins):UC Riverside plant pathologist receives national recognition 2Not at home on the range 2Not at home on the range 3Not at home on the range 4
... COLUMBUS, Ohio Ohio State University cancer researchers ... brain-tumor cells and blocks the growth of new tumor ... to kill cancer cells oncolytic viruses might ... also carry a gene for a protein that inhibits ...
... NEW YORK, Dec. 1 iQor, a global provider of business ... 100 Awards Top 100 IT project of 2009 for its ... , "We are honored to be recognized among this prestigious list ... is completely transforming the way we do business, allowing us to ...
... bad cold, can spread among groups of people, research ... Diego and Harvard shows. Using longitudinal data from a ... more than 60 years, a team of scholars found ... others. Gradually over time, a group of lonely, disconnected ...
Cached Biology News:Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3
(Date:1/14/2014)... January 14, 2014 iLab Solutions, the leader ... the new Director of Product Strategy. In this role, Michelle ... iLab sub-teams to guide in the development of iLab products. ... the maximum possible benefit to the scientific community by offering ...
(Date:1/14/2014)... 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a ... innovative therapies addressing major unmet medical needs using ... Notice of Allowance from the United States Patent ... compounds (sd-rxRNA®), for the treatment of fibrosis. The ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, provider of ... ) and sales and operations planning ( S&OP ) service, ... Biomanufacturing Summit , which will be held at the Hilton ... conference, join Kinaxis customer Elisabeth Kaszas , Director of ...
(Date:1/14/2014)... 14, 2014 Kerr Corporation, a leading manufacturer ... additional how-to information about dual arch impressions on its dental ... Arch Impressions,” the blog entry serves up a list of ... a step-by-step demonstration by Dr. David Little as he crafts ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... 1 Iomai Corporation,(Nasdaq: IOMI ) ... merger of,Iomai with a wholly-owned subsidiary of ... shares entitled to vote at the special,meeting ... of the,votes cast. The transaction remains subject ...
... MS, EDMONTON, Aug. 1 /PRNewswire-FirstCall/ - BioMS ... treatment of multiple sclerosis (MS), today,announced that it ... trial of MBP8298 (dirucotide) for the treatment of ... approximately,510 patients, and is being conducted at 68 ...
... Associates has announced the development of the Core Communications Program, ... investors, collaborators, and customers. , ... ... http://www.mainsgate.com [Mains Associates] has announced the availability of ...
Cached Biology Technology:BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 2BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 3BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial 4Bay-Area Company Gives Science-Based Startups a Voice 2
... 26] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min....
One-step, microplate or cuvet, colorimetric, linear detection range 0.9 mg/dL to 200 mg/dL. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
Biology Products: